raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:444458

Combined oxidative phosphorylation defect type 24

Synonyms: COXPD24

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Infancy
Status
active

Combined oxidative phosphorylation defect type 24 is a rare mitochondrial oxidative phosphorylation disorder characterized by variable phenotype, including developmental delay with psychomotor regression, intellectual disability, epilepsy, Leigh syndrome, non-syndromic hearing loss, visual impairment and severe myopathy. Decreased activity of mitochondrial respiratory complexes and lactic acidosis are common findings, and diffuse cerebral atrophy may be associated.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enCombined oxidative phosphorylation defect type 24COXPD24
frDéficit combiné de la phosphorylation oxydative type 24= en
deKombinierter Defekt der oxidativen Phosphorylierung Typ 24= en
esDeficiencia combinada de la fosforilación oxidativa tipo 24= en
itDifetto combinato della fosforilazione ossidativa tipo 24= en
nlGecombineerde oxidatieve fosforylatiedeficiëntie type 24COXPD24 · Gecombineerde oxidatieve fosforyleringdeficiëntie type 24
ptDéfice combinado da fosforilação oxidativa tipo 24
plZłożony defekt fosforylacji oksydacyjnej typu 24= en
csKombinovaný deficit oxidativní fosforylace, typ 24= en
ukКомбінований дефект окисного фосфорилювання, тип 24= en
zh联合氧化磷酸化缺陷24型= en
trKombine oksidatif fosforilasyon defekti tip 24= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM616239Evalidated
ICD-10E88.8NTBTattributedvalidated
ICD-115C53.23NTBTattributedvalidated
MONDO0014547Evalidated
UMLSC4015643Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
NARS2Disease-causing germline mutation(s) inAssessedHGNC:26274ENSG0000013751361280311q14.1asparaginyl-tRNA synthetase 2, mitochondrial25385316[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families3 casesWorldwideCase(s)Validated25629079[PMID]_25385316[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_25629079[PMID]_25385316[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card